1. Home
  2. STRO vs NREF Comparison

STRO vs NREF Comparison

Compare STRO & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • NREF
  • Stock Information
  • Founded
  • STRO 2003
  • NREF 2019
  • Country
  • STRO United States
  • NREF United States
  • Employees
  • STRO N/A
  • NREF N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • NREF Real Estate Investment Trusts
  • Sector
  • STRO Health Care
  • NREF Real Estate
  • Exchange
  • STRO Nasdaq
  • NREF Nasdaq
  • Market Cap
  • STRO 292.6M
  • NREF 265.1M
  • IPO Year
  • STRO 2018
  • NREF 2020
  • Fundamental
  • Price
  • STRO $4.17
  • NREF $15.90
  • Analyst Decision
  • STRO Strong Buy
  • NREF Hold
  • Analyst Count
  • STRO 8
  • NREF 3
  • Target Price
  • STRO $12.13
  • NREF $13.75
  • AVG Volume (30 Days)
  • STRO 496.5K
  • NREF 36.1K
  • Earning Date
  • STRO 11-19-2024
  • NREF 10-31-2024
  • Dividend Yield
  • STRO N/A
  • NREF 12.51%
  • EPS Growth
  • STRO N/A
  • NREF N/A
  • EPS
  • STRO N/A
  • NREF 1.43
  • Revenue
  • STRO $169,359,000.00
  • NREF $75,881,000.00
  • Revenue This Year
  • STRO N/A
  • NREF N/A
  • Revenue Next Year
  • STRO N/A
  • NREF $40.88
  • P/E Ratio
  • STRO N/A
  • NREF $11.21
  • Revenue Growth
  • STRO 197.83
  • NREF 236.07
  • 52 Week Low
  • STRO $2.01
  • NREF $12.63
  • 52 Week High
  • STRO $6.13
  • NREF $17.25
  • Technical
  • Relative Strength Index (RSI)
  • STRO 64.22
  • NREF 61.12
  • Support Level
  • STRO $3.22
  • NREF $14.82
  • Resistance Level
  • STRO $3.74
  • NREF $15.99
  • Average True Range (ATR)
  • STRO 0.24
  • NREF 0.46
  • MACD
  • STRO 0.08
  • NREF 0.18
  • Stochastic Oscillator
  • STRO 78.99
  • NREF 97.99

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. It provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

Share on Social Networks: